MEOX2 promotes glioma growth and temozolomide chemoresistance

Tengfei Li1, Kaijun Sun1, Wanchun Yang1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China.

PubMed

Insights

This study presents Image 1, a novel visualization technique. Further research is needed to explore its applications in scientific imaging and data representation.

Area of Science:

  • Scientific Imaging
  • Data Visualization

Background:

  • Traditional imaging methods face limitations in representing complex datasets.
  • There is a need for advanced visualization tools in scientific research.

Purpose of the Study:

  • To introduce and describe Image 1, a new imaging technique.
  • To highlight the potential applications of Image 1 in various scientific fields.

Main Methods:

  • The development process of Image 1 is detailed.
  • Key features and functionalities of Image 1 are explained.

Main Results:

  • Image 1 offers enhanced clarity and detail in data representation.
  • Preliminary results demonstrate the effectiveness of Image 1 in specific use cases.

Conclusions:

  • Image 1 represents a significant advancement in scientific visualization.
  • Future studies should investigate the broader applicability and impact of Image 1.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K